Added to YB: 2024-11-07
Pitch date: 2024-11-04
OMIC [neutral]
Singular Genomics Systems, Inc.
-9.99%
current return
Author Info
Clark Street Value is a special sits/event-driven investor. Sign up for the newsletter.
Company Info
Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and spatial multiomics technology for researchers and clinicians to advance science and medicine.
Market Cap
$50.6M
Pitch Price
$22.23
Price Target
24.00 (+20%)
Dividend
N/A
EV/EBITDA
0.10
P/E
-0.57
EV/Sales
-2.94
Sector
Life Sciences Tools and Services
Category
special_situation
Singular Genomics Systems: Exclusivity Period w/ Deerfield, Spread Remains
OMIC (merger arb - buy below 22): Deerfield's $24/share bid, 11.6% spread. NCAV ~$20-24/share at close. G4X launch Q2 2025 could be inflection point. Competitive process w/ Tang's $12 bid. Cash burn $25M/quarter. Downside risk, but credible buyer. Similar to ASXC deal. Buy below $22, slight chance of bump.
Read full article (2 min)